ESC 365 - Comparative cost-effectiveness of atrial fibrillation ablation versus pharmacological therapy.

EHRA Premium Access

Comparative cost-effectiveness of atrial fibrillation ablation versus pharmacological therapy.

Session: Is it worth the money? Cost-effectiveness in electrophysiology

Topic: Policy initiative

Speaker: Doctor J. Caldwell (Hull, GB)

Event: EHRA EUROPACE - CARDIOSTIM 2017

Congress Presentation

Add to my library

About the speaker

Doctor Jane Cochrane Caldwell

Hull and East Yorkshire Hospitals NHS Trust, Hull (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

3 more presentations in this session

Patient compliance and outcomes of pharmacological therapy and atrial fibrillation ablation.

Speaker: Professor S. Saksena (Warren, US)

Commissioning and reimbursement of atrial fibrillation ablation in Europe.

Speaker: Professor F. Braunschweig (Stockholm, SE)

The role of the ESC Health Policy: relevance to electrophysiology and cardiac device practice.

Speaker: Professor P. Vardas (Heraklion, GR)

Access the full session

Is it worth the money? Cost-effectiveness in electrophysiology

Speakers: Doctor J. Caldwell, Professor S. Saksena, Professor F. Braunschweig, Professor P. Vardas

About the event

EHRA EUROPACE - CARDIOSTIM 2017

18 June - 21 June 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources